Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Monigen XL 60 tablets
0206010K0CJAAAE
|
Monigen | Isosorbide mononitrate | Cardiovascular System | No data available |
|
Monit 20mg tablets
0206010K0BEAAAC
|
Monit | Isosorbide mononitrate | Cardiovascular System | No data available |
|
Monit SR 40mg tablets
0206010K0BEACAG
|
Monit | Isosorbide mononitrate | Cardiovascular System | No data available |
|
Monit XL60 tablets
0206010K0BEADAE
|
Monit | Isosorbide mononitrate | Cardiovascular System | No data available |
|
Monosorb XL 60 tablets (Teva)
0206010K0CCACAE
|
Monosorb | Isosorbide mononitrate | Cardiovascular System | No data available |
|
Phasonit LA50 capsules
0206010K0CQABAF
|
Phasonit | Isosorbide mononitrate | Cardiovascular System | No data available |
|
Slomon XL 60 tablets
0206010K0CFAAAE
|
Slomon | Isosorbide mononitrate | Cardiovascular System | No data available |
|
Zemon 60 XL tablets
0206010K0CEAAAE
|
Zemon | Isosorbide mononitrate | Cardiovascular System | No data available |
|
Zevona XL 30mg tablets
0206010K0CWAABD
|
Zevona XL | Isosorbide mononitrate | Cardiovascular System | No data available |
|
Ziotan XL 50mg capsules
0206010K0CPAAAF
|
Ziotan | Isosorbide mononitrate | Cardiovascular System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.